Sure, I could start taking a look at SEER if you want to start
looking at ADNI...
Daniel
At 02:23 PM 10/4/2007, Matt Williams wrote:
If work goes well tomorrow, perhaps.
Else perhaps Monday pm.
Daniel - can we divide this sensibly?
Matt
Susie Stephens wrote:
Hi Matt, Daniel,
It would be great if you were able to write a brief description of
the data set, list the terms that are used, and also provide some
information as to how the data is currently used.
Would it be realistic for either of you to get that done by Monday?
Cheers,
Susie
On 10/4/07, *Daniel Rubin* <[EMAIL PROTECTED]
<mailto:[EMAIL PROTECTED]>> wrote:
I might be able to help look as some of these data, depending on
what specifically is expected for this task.
Regards,
Daniel
___
Daniel Rubin, MD, MS
Clinical Asst. Professor, Radiology
Research Scientist, Stanford Medical Informatics
Scientific Director, National Center of Biomedical Ontology
MSOB X-215
Stanford, CA 94305
650-725-5693
At 09:16 AM 10/4/2007, Susie Stephens wrote:
Assessing clinical data sets for incorporation into our work
sounds like an excellent idea. I'll add that as an agenda item for
Monday's BioRDF call as suggested by EricN.
It would be wonderful is someone wants to volunteer to take a look
at the cancer data set that Alan uncovered (
<http://seer.cancer.gov/data/> http://seer.cancer.gov/data/). If
someone has the bandwidth by Monday then that would be great, but
providing feedback the week after would also be excellent.
Another data set that I think is interesting is the one being
developed by the Alzheimers Disease NeuroImaging Initiative (
http://www.loni.ucla.edu/ADNI/). This is an open data set that
includes serial magnetic resonance imaging (MRI), positron
emission tomography (PET), other biological markers, and clinical
and neuropsychological assessment data. The goal of the data is to
use it to learn about the progression of mild cognitive impairment
and early Alzheimer's disease. I'm definitely going to be
exploring this data further, but I'd be more than happy for other
folks to take a look at it too.
Cheers,
Susie
On 10/4/07, *Eric Neumann* <[EMAIL PROTECTED]
<mailto:[EMAIL PROTECTED]>> wrote:
Indeed this would be an interesting set to rdf-ize. It might
also be interesting based on the dataset complexity (i.e.,
moderate complexity) to see what practical stratgey for RDF
conversion one would choose.
http://seer.cancer.gov/data/
Perhaps a few folks could look at this data structure,
consider some approaches ( e.g., RDF-Schema only vs. a minimal
ontology), and discuss this on the next BioRDF call?
Eric
-----Original Message-----
From: [EMAIL PROTECTED]
<mailto:[EMAIL PROTECTED]> on behalf of
Alan Ruttenberg
Sent: Wed 10/3/2007 1:07 AM
To: public-semweb-lifesci hcls
Subject: Surveillance Epidemiology and End Results (SEER)
At a talk I attended today, this resource of patient cancer
diagnoses was mentioned as an example of publicly
available clinical
data. A
quick look over the documentation suggests it might be an
interesting
project to produce an RDF version of the data set.
http://seer.cancer.gov/data/
The SEER limited-use data* include SEER incidence and
population data
associated by age, sex, race, year of diagnosis, and
geographic areas
(including SEER registry and county)
-Alan
--
http://acl.icnet.uk/~mw
http://adhominem.blogsome.com/
+44 (0)7834 899570
